PolyPid to Participate in ROTH Capital Partners Virtual KOL Event on December 10, 2025

PETACH TIKVA, Israel, Nov. 25, 2025 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will participate in a virtual Key Opinion Leader (KOL) event hosted by ROTH Capital Partners.
KOL Event Information:
Webinar Title: The Science and Business Case for D-PLEX100 (Tackling Surgical Site Infections)
Date: Wednesday, December 10, 2025
Time: 11:30 AM Eastern Time
Webcast link: https://vimeo.com/1156959495?share=copy&fl=sv&fe=ci